N/A
Completed N=29
AdheRence to Inhaled Corticosteroids in Asthma
Medication Adherence · Asthma
Source: ClinicalTrials.gov NCT03769519 ↗
Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Dec 2021
Primary outcomePrimary: Number of Participants Who Reported Experiences With the ARICA Program — 12 Participants
Summary
It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Reported Experiences With the ARICA Program |
12 | — |
| SECONDARY Change in Patient Reported Medication Adherence as Measured by the DOSE-Nonadherence (Voils) Questionnaire |
0.685; 0.738 | — |
| SECONDARY Change in Asthma Control as Measured by the Asthma Control Test |
-2.571; -3.5 | — |
| SECONDARY Change in Asthma-Related Quality of Life as Measured by the Marks Asthma-Related Quality of Life Questionnaire |
5.769; 11.462 | — |
Eligibility Criteria
Inclusion Criteria
- At least 18 years of age
- Self-identifying African American
- Self-reported current asthma
- Prescribed an inhaled corticosteroid (alone or combination) for ≥ 1 month
- Presented at a Duke Primary Care clinic visit within the past 3 years or is establishing care at Duke Primary Care
- Follow up Duke Primary Care visit within the next 6 months
Exclusion Criteria
- Unable or unwilling to provide informed consent
Data sourced from ClinicalTrials.gov (NCT03769519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.